tiprankstipranks
Coeptis Therapeutics Holdings (COEP)
NASDAQ:COEP
US Market

Coeptis Therapeutics Holdings (COEP) Stock Investors

100 Followers
Based on 747,525 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold COEP
On average, investors allocate 0.00% of their portfolios to COEP
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 747,525 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding COEP

1.7%
Last 7
Days
5.6%
Last 30
Days
Percentages indicate the change in the number of portfolios holding COEP, out of 747,525 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

COEP Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,193 investors who made their portfolios public
The table shows changes in COEP in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

COEP Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Citigroup
4.93%
-0.39%
+0.76%
124.25B
Financial
Riot Platforms
5.14%
-0.29%
+0.16%
3.47B
Financial
ChargePoint Holdings
4.18%
-1.24%
-2.42%
833.60M
Consumer Cyclical
DraftKings
5.81%
-1.05%
-1.92%
32.41B
Consumer Cyclical
Cisco Systems
4.25%
-1.09%
+0.41%
190.64B
Technology
Airbnb
4.47%
-1.14%
+2.23%
95.31B
Consumer Cyclical
Blink Charging Co
5.22%
-1.56%
-4.77%
315.31M
Industrials
Trade Desk
4.67%
-1.20%
+0.26%
46.96B
Technology
Echostar
3.08%
-1.69%
-5.46%
5.24B
Technology
UiPath
3.31%
-1.12%
-2.81%
6.90B
Technology
Based on the activity of 747,525 active portfolios
Open your Smart Portfolio

COEP Investor Analysis

COEP investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
25.0%
of COEP holders
are under 35
Average Segment Performance
Average P/E Ratio20.77
Beta7.15
Dividend Yield6.79%
COEP investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
25.0%
of COEP holders
are between 35–55
Average Segment Performance
Average P/E Ratio19.59
Beta11.22
Dividend Yield6.44%
COEP investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
50.0%
of COEP holders
are over 55
Average Segment Performance
Average P/E Ratio19.41
Beta3.84
Dividend Yield7.80%
Overview of age group and performance of COEP stock investors
See who invests in COEP according to age group and performance.

FAQ

How many retail Investors hold COEP?
<0.1% of TipRanks' retail investors hold COEP in their portfolios.
    What is COEP Investor Sentiment?
    COEP’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of COEP in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of COEP in the last 7 days.
        What percentage of retail investors changed their holding of COEP in the last 30 days?
        ▼ 5.6% of TipRanks' retail investors changed their holding of COEP in the last 30 days.
          What is the average age of retail investors who hold COEP?
          The average age of COEP Holders is over 55.
            What other stocks have COEP investors also bought?
            COEP Investors also bought C, RIOT, CHPT, DKNG, CSCO, ABNB, BLNK, TTD, SATS, PATH.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ALNYAlnylam Pharma
              BCRXBioCryst
              DHRDanaher
              EWEdwards Lifesciences
              AVDLAvadel Pharmaceuticals
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis